Forskning ved Københavns Universitet - Københavns Universitet


Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

  • Schmiegelow, K.
  • Muller, Klaus
  • Signe Sloth Mogensen
  • Pernille Rudebeck Mogensen
  • Benjamin Ole Wolthers
  • Ulrik Kristoffer Stoltze
  • Ruta Tuckuviene
  • Thomas Frandsen

During chemotherapy for childhood acute lymphoblastic leukemia, all organs can be affected by severe acute side effects, the most common being opportunistic infections, mucositis, central or peripheral neuropathy (or both), bone toxicities (including osteonecrosis), thromboembolism, sinusoidal obstruction syndrome, endocrinopathies (especially steroid-induced adrenal insufficiency and hyperglycemia), high-dose methotrexate-induced nephrotoxicity, asparaginase-associated hypersensitivity, pancreatitis, and hyperlipidemia. Few of the non-infectious acute toxicities are associated with clinically useful risk factors, and across study groups there has been wide diversity in toxicity definitions, capture strategies, and reporting, thus hampering meaningful comparisons of toxicity incidences for different leukemia protocols. Since treatment of acute lymphoblastic leukemia now yields 5-year overall survival rates above 90%, there is a need for strategies for assessing the burden of toxicities in the overall evaluation of anti-leukemic therapy programs.

Antal sider14
StatusUdgivet - 2017

Antal downloads er baseret på statistik fra Google Scholar og

Ingen data tilgængelig

ID: 196132293